High-risk localised prostate cancer: multimodal treatment strategies combining neoadjuvant hormonal therapy and/or chemotherapy with radical prostatectomy-Reference-Cited by-同舟云学术

High-risk localised prostate cancer: multimodal treatment strategies combining neoadjuvant hormonal therapy and/or chemotherapy with radical prostatectomy

Published:2003-11 Issue:2 Volume:8 Page:291-295
ISSN:1472-8214
Container-title:Expert Opinion on Emerging Drugs
language:en
Short-container-title:Expert Opinion on Emerging Drugs

Author:

Eastham James A

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology

Link

http://www.tandfonline.com/doi/pdf/10.1517/14728214.8.2.291

Reference19 articles.

1. Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and gleason score in men with clinically localized prostate cancer

2. Radical Prostatectomy Nomograms in Black American Men: Accuracy and Applicability

3. Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

4. NEOADJUVANT HORMONAL ABLATIVE THERAPY BEFORE RADICAL PROSTATECTOMY: A REVIEW. IS IT INDICATED?

5. Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toxicity in patients receiving adjuvant docetaxel + hormonal treatment after radical radiotherapy for intermediate or high-risk prostate cancer: a preplanned safety report of the SPCG-13 trial;Prostate Cancer and Prostatic Diseases;2012-05-01

2. Treatment of Prostate Cancer in the 21st Century—Future Directions;European Urology Supplements;2006-09

3. High-Risk Localized Prostate Cancer: Integrating Chemotherapy;The Oncologist;2005-10-01